Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. - Gnant,M.F.; Mlineritsch,B.; Luschin-Ebengreuth,G. (J Clin Oncol, 2007)